Laddar...
MiR-93 Promotes Tumorigenesis and Metastasis of Non-Small Cell Lung Cancer Cells by Activating the PI3K/Akt Pathway via Inhibition of LKB1/PTEN/CDKN1A
Background: Non-small cell lung cancer (NSCLC) accounts for approximately 85% of clinical lung cancer cases. MicroRNA-93 (miR-93) is an oncomiR in many types of human cancer, exerting pivotal effects in the development and progression of malignancies, including NSCLC. However, the mechanism underlyi...
Sparad:
| I publikationen: | J Cancer |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Ivyspring International Publisher
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381176/ https://ncbi.nlm.nih.gov/pubmed/28382150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.17958 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|